| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
* To whom correspondence should be addressed. E-mail: gail.cornwall{at}ttuhsc.edu.
The Cres gene defines a new subgroup in the family 2
cystatins of cysteine protease inhibitors. However,
unlike typical cystatins, CRES does not inhibit cysteine
proteases but rather inhibits the serine protease
prohormone convertase 2, an enzyme with roles in
proprotein processing in the neuroendocrine system. Cres
is expressed in the gonadotropes and colocalizes with
LH
suggesting a role in the regulation of
gonadotrope secretion. Our present studies were carried
out to examine the regulation of Cres mRNA and protein
expression by GnRH and steroid hormones thus providing
clues regarding its role in gonadotropes.
Castration profoundly reduced Cres mRNA while replacement
with estradiol (E2), testosterone (T), or
dihydrotestosterone (DHT) further decreased Cres
suggesting negative regulation by GnRH or steroid
hormones. The administration of Antide, a GnRH
antagonist, resulted in a 3-fold increase in Cres mRNA
supporting a negative regulation by GnRH. Because all
hormonal manipulations in vivo resulted in alterations in
steroid hormones, organ culture was used to assess the
effects of GnRH independent of steroids. Mouse
pituitaries cultured in the absence of GnRH or steroids
showed high Cres mRNA levels while DHT or E2 resulted in a
25 % and 68% decrease, respectively. However, an 85%
decrease in Cres mRNA occurred following the
administration of GnRH demonstrating that GnRH, and to a
lesser degree E2, negatively regulate Cres mRNA in
gonadotropes.
Examination of CRES protein by immunohistochemistry showed
that levels were profoundly reduced following castration
while DHT, and in part T, but not E2 restored CRES levels.
Castrated mice treated with Antide resulted little
effect. However, castrated mice treated with Antide +DHT
showed a dramatic recovery of CRES suggesting that
androgens act directly at the level of the gonadotrope to
regulate CRES protein. Together, our studies suggest that
Cres mRNA and protein are low at peak gonadotrope
secretory activity possibly as a means to allow proprotein
processing events to occur that are integral to
gonadotrope function.
Key words: Androgen
Hormone
GnRH
cystatin-related
gonadtrope
neuroendocrine
pituitary gland
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |